We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.79B
AUM Growth
+$1.29B
Cap. Flow
+$933M
Cap. Flow %
13.74%
Top 10 Hldgs %
15.83%
Holding
1,205
New
433
Increased
209
Reduced
253
Closed
295

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$67.3M
2
PPG icon
PPG Industries
PPG
+$49.7M
3
AAPL icon
Apple
AAPL
+$46.8M
4
MU icon
Micron Technology
MU
+$42.1M
5
HRB icon
H&R Block
HRB
+$41.7M

Sector Composition

Rank Sector Weight
1 Industrials 12.8%
2 Communication Services 12.26%
3 Healthcare 12.21%
4 Materials 11.4%
5 Financials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBHC icon
876
National Bank Holdings
NBHC
$1.93B
$152K ﹤0.01%
+7,600
New +$149K
PLXS icon
877
Plexus
PLXS
$6.81B
$152K ﹤0.01%
+3,500
New +$146K
HERO
878
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
$152K ﹤0.01%
+37,864
New +$169K
ASCMA
879
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$152K ﹤0.01%
+2,300
New +$153K
LNCE
880
DELISTED
Snyders-Lance, Inc.
LNCE
$146K ﹤0.01%
+5,500
New +$148K
CME icon
881
CME Group
CME
$92.2B
$142K ﹤0.01%
+1,996
New +$140K
WLT
882
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$139K ﹤0.01%
25,500
-15,300
-38% -$97.2K
ENTA icon
883
Enanta Pharmaceuticals
ENTA
$372M
$138K ﹤0.01%
+3,215
New +$123K
BCIC
884
BCP Investment Corp
BCIC
$86.9M
$137K ﹤0.01%
+1,610
New +$130K
CUDA
885
DELISTED
Barracuda Networks, Inc.
CUDA
$134K ﹤0.01%
4,309
-33,609
-89% -$962K
ANK
886
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
$133K ﹤0.01%
+2,300
New +$133K
IPHS
887
DELISTED
Innophos Holdings, Inc.
IPHS
$132K ﹤0.01%
+2,300
New +$125K
AJRD
888
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$130K ﹤0.01%
+6,800
New +$124K
ARO
889
DELISTED
Aeropostale Inc
ARO
$121K ﹤0.01%
34,625
-20,775
-38% -$88.3K
ONE
890
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$120K ﹤0.01%
31,500
-18,900
-38% -$92.4K
ADI icon
891
Analog Devices
ADI
$181B
$115K ﹤0.01%
+2,135
New +$113K
PTLA
892
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$114K ﹤0.01%
+3,903
New +$94.5K
FDUS icon
893
Fidus Investment
FDUS
$737M
$109K ﹤0.01%
+5,300
New +$98.7K
NSLR
894
Neostellar Capital Corp
NSLR
$262M
$98K ﹤0.01%
+14,323
New +$89.3K
RCPI
895
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$88K ﹤0.01%
+5,971
New +$104K
EPAM icon
896
EPAM Systems
EPAM
$4.69B
$83K ﹤0.01%
1,894
-19,370
-91% -$732K
RMTI icon
897
Rockwell Medical
RMTI
$26.2M
$83K ﹤0.01%
63
-71
-53% -$85.4K
ALEX
898
DELISTED
Alexander & Baldwin
ALEX
$82K ﹤0.01%
+1,978
New +$78K
BKU icon
899
Bankunited
BKU
$3.38B
$80K ﹤0.01%
2,403
-323,336
-99% -$10.7M
SRE icon
900
Sempra
SRE
$60.8B
$75K ﹤0.01%
1,442
-19,826
-93% -$985K

Similar funds

Marshall Wace's Q2 2014 Portfolio in Review

As of Q2 2014, Marshall Wace held 1,205 positions worth $6.79B, up 24% from $5.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $933M of net new capital in Q2 2014, opening 433 new positions and adding to 209 existing holdings. Its largest new stake was H&R Block: 1,400,000 shares worth $46.9M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SANDISK CORP, an estimated $35.8M trimmed.

  • Marshall Wace's largest Q2 2014 buy was H&R Block: 1,400,000 shares worth $46.9M.
  • Marshall Wace added most to Lazard in Q2 2014, an estimated $67.3M increase.
  • Marshall Wace's biggest Q2 2014 reduction was SANDISK CORP, cutting an estimated $35.8M.
  • Marshall Wace fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q2 2014, selling an estimated $54.9M.
  • Marshall Wace's ten largest holdings make up 16% of its $6.79B portfolio in Q2 2014.
  • Marshall Wace opened 433 new positions and closed 295 in Q2 2014.
  • Marshall Wace's portfolio value rose 24% quarter-over-quarter to $6.79B.

Based on Marshall Wace's 13F filing for Q2 2014, filed 14 Aug 2014.